Next Article in Journal
Using a Material Library to Understand the Impacts of Raw Material Properties on Ribbon Quality in Roll Compaction
Previous Article in Journal
Investigation of Silicone-Containing Semisolid in Situ Film-Forming Systems Using QbD Tools
Open AccessArticle

A Novel Hybrid Additive Manufacturing Process for Drug Delivery Systems with Locally Incorporated Drug Depots

1
Microfluidics, Faculty of Mechanical Engineering and Marine Technology, University of Rostock, Justus-von-Liebig Weg 6, 18059 Rostock, Germany
2
Institute for Biomedical Engineering, University Medical Center Rostock, Friedrich-Barnewitz-Straße 4, 18119 Rostock, Germany
3
Department LL&M, Interdisciplinary Faculty, University of Rostock, Rostock, Albert-Einstein-Str. 25, 18059 Rostock, Germany
*
Author to whom correspondence should be addressed.
Pharmaceutics 2019, 11(12), 661; https://doi.org/10.3390/pharmaceutics11120661
Received: 10 November 2019 / Revised: 2 December 2019 / Accepted: 4 December 2019 / Published: 7 December 2019
Here, we present a new hybrid additive manufacturing (AM) process to create drug delivery systems (DDSs) with selectively incorporated drug depots. The matrix of a DDS was generated by stereolithography (SLA), whereas the drug depots were loaded using inkjet printing. The novel AM process combining SLA with inkjet printing was successfully implemented in an existing SLA test setup. In the first studies, poly(ethylene glycol) diacrylate-based specimens with integrated depots were generated. As test liquids, blue and pink ink solutions were used. Furthermore, bovine serum albumin labeled with Coomassie blue dye as a model drug was successfully placed in a depot inside a DDS. The new hybrid AM process makes it possible to place several drugs independently of each other within the matrix. This allows adjustment of the release profiles of the drugs depending on the size as well as the position of the depots in the DDS. View Full-Text
Keywords: drug delivery system; hybrid additive manufacturing process; stereolithography; inkjet printing; drug depot; time-controlled drug release; poly(ethylene glycol) diacrylate (PEGDA) drug delivery system; hybrid additive manufacturing process; stereolithography; inkjet printing; drug depot; time-controlled drug release; poly(ethylene glycol) diacrylate (PEGDA)
Show Figures

Graphical abstract

MDPI and ACS Style

Konasch, J.; Riess, A.; Mau, R.; Teske, M.; Rekowska, N.; Eickner, T.; Grabow, N.; Seitz, H. A Novel Hybrid Additive Manufacturing Process for Drug Delivery Systems with Locally Incorporated Drug Depots. Pharmaceutics 2019, 11, 661.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop